UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Ways To Cut Costs After Budgeting Mistakes highlights actionable strategies to trim spending and reclaim financial momentum quickly.
25,117 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Goldman Sachs raises price targets on three major tech names by roughly 10%, reflecting improved growth visibility as...
Dividend investing can deliver steady income even when markets swing. Here are three no-brainer dividend stocks right...
IBM has delivered a multiyear rally, but a 2026 pullback creates a buying opportunity for patient investors. This gui...
When a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
Rocket Lab faces a pivotal Q1 print this evening as analysts weigh Neutron timing against a record backlog. Guidance ...
A new AI-driven forecast puts Solana on a trajectory to smash expectations by late 2026, driven by on-chain adoption ...
Bitcoin slid to a two-week low near $78,000 after a brief run to the mid-80s, throwing cold water on a quick bear-mar...
A 66-year-old couple with $850,000 can generate about $4,612 a month using a tax-efficient three-bucket income plan t...
A billionaire shifted away from cloud giants to AI infrastructure plays. This article explains what drove the move an...
U.S. equities moved higher on Thursday as a wave of fresh Wall Street analyst calls buoyed major names across healthc...
When a top actor hints at a future hand-off, it isn’t just about storytelling. It’s a real-world lesson in financial ...